Clinical Trial Update: Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) [NA]

View source ↗

Summary

This update notes the completion of a compassionate-use trial of Brontictuzumab for Adenoid Cystic Carcinoma, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Brontictuzumab (Brontictuzumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Adenoid Cystic Carcinoma | NA | Status: COMPLETED | Results posted: 2017-05-16